The expression of progesterone receptors coincides with an arrest of DNA synthesis in human breast cancer

Two main models to account for the heterogeneous expression of estrogen receptors (ER) and progesterone receptors (PR) in human breast cancer have been proposed: the clonal model and the stem cell model. The authors previously provided evidence supporting the stem cell model since it was found that...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Ballare, C., Bravo, A.I., Sorin, I., Guman, N., Schiaffi, J.A., Yomha, R., Bagnati, A., Lema, B., Mordoh, J.
Formato:	JOUR
Materias:	progesterone receptor antigen expression article autoradiography breast cancer clinical article dna synthesis female growth inhibition human human tissue immunohistochemistry priority journal Breast Neoplasms Carcinoma DNA Replication DNA, Neoplasm Female Human Immunohistochemistry Receptors, Estrogen Receptors, Progesterone Reproducibility of Results Support, Non-U.S. Gov't
Acceso en línea:	http://hdl.handle.net/20.500.12110/paper_0008543X_v67_n5_p1352_Ballare
Aporte de:	Biblioteca Digital - Facultad de Ciencias Exactas y Naturales (UBA) de Universidad de Buenos Aires

Ejemplares similares

The expression of progesterone receptors coincides with an arrest of DNA synthesis in human breast cancer
por: Ballaré, Cecilia J.
Publicado: (1991)

Binding of estradiol receptor complexes to isolated human breast chromatin
por: Charreau, E.H., et al.

Marker Expression and Differentiation in Human Breast Cancer
por: BALLARE, C., et al.

Binding of estradiol receptor complexes to isolated human breast chromatin
Publicado: (1977)

Marker Expression and Differentiation in Human Breast Cancer
Publicado: (1993)

Description of a new human breast cancer cell line, IIB-BR-G, established from a primary undifferentiated tumor
por: Bover, L., et al.

Estrogen receptors α and β and progesterone receptors in normal bovine ovarian follicles and cystic ovarian disease
por: Salvetti, Natalia R., et al.
Publicado: (2007)

Induccion de adenocarcinomas mamarios por progestagenos en ratones BALB/c: Progresion del tumor hormono-dependiente al autonomo
por: Lanari, C., et al.

Description of a new human breast cancer cell line, IIB-BR-G, established from a primary undifferentiated tumor
por: Bover, Laura del Carmen, et al.
Publicado: (1991)

Induccion de adenocarcinomas mamarios por progestagenos en ratones BALB/c: Progresion del tumor hormono-dependiente al autonomo
Publicado: (1997)

Transcriptional features of fractionated human breast tumor chromatin
por: Thierbach, L.I.A., et al.

Chronic expression of wild-type Ret receptor in the mammary gland induces luminal tumors that are sensitive to Ret inhibition
por: Gattelli, A., et al.

Association of estrogen receptor-α and progesterone receptor A expression with hormonal mammary carcinogenesis: Role of the host microenvironment
por: Montero Girard, G., et al.

Chronic expression of wild-type Ret receptor in the mammary gland induces luminal tumors that are sensitive to Ret inhibition
Publicado: (2018)

Association of estrogen receptor-α and progesterone receptor A expression with hormonal mammary carcinogenesis: Role of the host microenvironment
Publicado: (2007)

Transcriptional features of fractionated human breast tumor chromatin
Publicado: (1979)

Progesterone receptor isoform ratio: a breast cancer prognostic and predictive factor for antiprogestin responsiveness
por: Rojas, Paola A., et al.
Publicado: (2017)

Classical membrane progesterone receptors in murine mammary carcinomas: Agonistic effects of progestins and RU-486 mediating rapid non-genomic effects
por: Bottino, M.C., et al.

Classical membrane progesterone receptors in murine mammary carcinomas: Agonistic effects of progestins and RU-486 mediating rapid non-genomic effects
por: Bottino, María Cecilia, et al.
Publicado: (2011)

Principles and practice of gynecologic oncology.
Publicado: (2009)

Changes in the peripheral blood and bone marrow from untreated advanced breast cancer patients that are associated with the establishment of bone metastases
por: Martinez, L.M., et al.

The human breast cancer cell line IIB-BR-G has amplified c-myc and c-fos oncogenes in vitro and is spontaneously metastatic in vivo.
por: Bover, L., et al.

Changes in the peripheral blood and bone marrow from untreated advanced breast cancer patients that are associated with the establishment of bone metastases
Publicado: (2014)

Biological activity and ligand binding mode to the progesterone receptor of A-homo analogues of progesterone
por: Alvarez, L.D., et al.

Heregulin induces transcriptional activation of the progesterone receptor by a mechanism that requires functional ErbB-2 and mitogen-activated protein kinase activation in breast cancer cells
por: Labriola, L., et al.

Activation of Stat3 by heregulin/ErbB-2 through the co-option of progesterone receptor signaling drives breast cancer growth
por: Proietti, C.J., et al.

Promoter effect of medroxyprogesterone acetate (MPA) in N-methyl-N-nitrosourea (MNU) induced mammary tumors in BALB/c mice
por: Pazos, P., et al.

Activation of Stat3 by heregulin/ErbB-2 through the co-option of progesterone receptor signaling drives breast cancer growth
Publicado: (2009)

Biological activity and ligand binding mode to the progesterone receptor of A-homo analogues of progesterone
por: Alvarez, Lautaro Damián, et al.
Publicado: (2011)

Heregulin induces transcriptional activation of the progesterone receptor by a mechanism that requires functional ErbB-2 and mitogen-activated protein kinase activation in breast cancer cells
Publicado: (2003)

Promoter effect of medroxyprogesterone acetate (MPA) in N-methyl-N-nitrosourea (MNU) induced mammary tumors in BALB/c mice
Publicado: (1998)

Carcinoma-associated fibroblasts activate progesterone receptors and induce hormone independent mammary tumor growth: A role for the FGF-2/FGFR-2 axis
por: Giulianelli, S., et al.

Progesterone receptor assembly of a transcriptional complex along with activator protein 1, signal transducer and activator of transcription 3 and ErbB-2 governs breast cancer growth and predicts response to endocrine therapy
por: Díaz Flaqué, M.C., et al.

Progesterone receptor assembly of a transcriptional complex along with activator protein 1, signal transducer and activator of transcription 3 and ErbB-2 governs breast cancer growth and predicts response to endocrine therapy
Publicado: (2013)

Mitoxantrone affects topoisomerase activities in human breast cancer cells
por: Crespi, M.D., et al.

Reversal of antiprogestin resistance and progesterone receptor isoform ratio in acquired resistant mammary carcinomas
por: Wargon, V., et al.

Chemiluminescence production by neutrophils and immune complex levels in cancer patients
por: Chasseing, N.A., et al.

Carcinoma-associated fibroblasts activate progesterone receptors and induce hormone independent mammary tumor growth: A role for the FGF-2/FGFR-2 axis
Publicado: (2008)

Mitoxantrone affects topoisomerase activities in human breast cancer cells
Publicado: (1986)

Reversal of antiprogestin resistance and progesterone receptor isoform ratio in acquired resistant mammary carcinomas
Publicado: (2009)